<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We measured serum <z:chebi fb="23" ids="18059">lipids</z:chebi>, <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> and post-<z:chebi fb="5" ids="28304">heparin</z:chebi> plasma lipases, <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase and hepatic lipase, in 12 female patients with Type 1 (insulin-dependent) <z:mp ids='MP_0002055'>diabetes</z:mp> (postglucagon C-<z:chebi fb="7" ids="16670">peptide</z:chebi> undetectable), in 11 female insulin-treated patients with Type 2 (non-insulin-dependent) <z:mp ids='MP_0002055'>diabetes</z:mp> (postglucagon C-<z:chebi fb="7" ids="16670">peptide</z:chebi> greater than 0.60 nmol/l) and in 16 non-diabetic female control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>These three groups of subjects were similar with respect to age and <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Insulin dose was similar in patients with Type 1 and with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="17" ids="39025">HDL</z:chebi> and HDL2 cholesterol were lower in patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> than in non-diabetic control subjects (p less than 0.05) but did not differ between patients with Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and non-diabetic control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>No difference in <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase activity was seen between the groups </plain></SENT>
<SENT sid="5" pm="."><plain>The highest levels of <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase and hepatic lipase activities were observed in patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="1" ids="6495">Lipoprotein</z:chebi> lipase activity correlated significantly with <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> in patients with Type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (p less than 0.01) and in patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (p less than 0.001) but not in control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>Hepatic lipase activity did not correlate significantly with <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> in any of the groups </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, postheparin plasma <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase and hepatic lipase activities do not seem to explain the difference in <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> concentration between patients with Type 1 and Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>